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High-performance  anion-exchange  chromatography  (HPAEC)  coupled  to pulsed  amperometric  detection
(PAD) is a  highly  sensitive  method  for  the  analysis  of  oligosaccharides  without  the  need  for prior  derivati-
zation.  However,  the  method  suffers  from  the  lack of  chemical  information  with  peak assignments  based
on  the  retention  times  of authentic  standards  or known  peaks  of  reference  materials.  Here  we applied
HPAEC  coupled  on-line  with  electrospray  ion  trap mass  spectrometry  (HPAEC-MS)  using a prototype
mini-bore  (1  mm  I.D.)  CarboPac  PA200  column  and  challenged  the  analytical  separation  based  method
for  the  structural  assignment  of heterogeneous  mixtures  of  N-glycans  derived  from  immunoglobulin  G
from human  plasma,  glyco-engineered  CHO  cells,  and  Sp2/0  mouse  myeloma  cells.  Compared  to  an  ana-
lytical scale  3  mm  I.D. column,  the mini-bore  column  demonstrated  a superior  performance  with  up  to
8-fold  improved  limit  of detection  for speciﬁc  N-glycans  determined  by PAD.  Quantitative  evaluation  by
extracted  ion  current  chromatograms  revealed  detection  limits  in the  50–100  femtomole  range  using
ion  trap  MS  operated  in  positive  ionization  mode.  In our  hands  HPAEC-MS/MS  allowed  the  detection  and
quantiﬁcation  of  even  low  abundant  glycan  species  including  biantennary  complex-type,  high  mannose,
hybrid  and  hybrid  bisected  structures.  In comparison  to the  detection  of N-glycans  as  lithiated  or  sodiated
adducts,  we  obtained  a 65-fold  improved  signal-to-noise  ratio  with  protonated  ions  only.  Relative  quan-
titative  evaluation  by single  ion  current  chromatograms  was  successfully  applied  and  demonstrated  an
excellent  performance  with  respect  to selectivity  in the  relative  quantiﬁcation  of  heterogeneous  samples
of N-glycans  compared  to HPAEC-PAD  and HILIC-UPLC  of 2-AB  labelled  N-glycans.
©  2016  The  Author(s).  Published  by Elsevier  B.V.  This  is  an  open  access  article  under  the  CC. Introduction
The distribution and type of N-linked glycans may  be criti-
al in the pharmacology of monoclonal antibodies (mAbs), one
f the most important classes of biologicals, potentially affect-
ng parameters like protein–protein interactions, immunogenicity,
harmaco-kinetics and −dynamics [1]. For these reasons the nec-
ssary product quality monitoring of therapeutic proteins requires
igh resolving and sensitive analytical tools for the characteriza-
ion of their glycosylation [2]. High-performance anion-exchange
hromatography (HPAEC) allows a powerful separation of carbo-
ydrates as their hydroxyl groups are in part deprotonated to
∗ Corresponding author.
E-mail address: michael.molhoj@roche.com (M.  Mølhøj).
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570-0232/© 2016 The Author(s). Published by Elsevier B.V. This is an open access articl
.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
oxyanions at high pH (>13.5). Due to subtle differences in the
pKa values of the different hydroxyl groups, the oxyanions of car-
bohydrates generated under highly alkaline conditions interact
differently with the positively charged stationary phase and facili-
tate their separation by anion-exchange mechanisms. This column
interaction is inﬂuenced by differences in size, linkage isomerism,
composition, charge, and branching of the carbohydrates [3–6].
Coupling of HPAEC to sensitive pulsed amperometric detection
(PAD) including gold electrode catalyzed anodic electro-oxidation
has been successfully applied to a wide range of carbohydrates
and oligosaccharides [4,6–9] with sensitivities down to picomole
levels [4,5,10]. Rohrer [11] and Behan and Smith [6] summarized
the inﬂuence on the retention time of the structure of N-linked
oligosaccharides, e.g. the presence of sialic acids (2,3- or 2,6-
linked), bisected GlcNAc, and number of 1,4-Gal residues linked
to GlcNAc. PAD detection does not directly provide any structural
e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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nformation needed for correct assignment of structurally complex
-glycans in a chromatogram. Due to the lack of several authen-
ic standards (e.g. hybrid bisected structures), correct structure
ssignment by HPAEC coupled with mass spectrometry will be very
seful.
The analysis of oligo- and polysaccharides by HPAEC coupled
o on-line desalting of the high salt concentrated eluent and mass
pectrometry has been described [12–19]. Nevertheless, the appli-
ation of HPAEC with on-line MS  has been partly hampered by the
ack of commercially available small-bore LC columns with their
mproved inﬂuence on gain in sensitivity, peak broadening, and
ncreased compatibility with low ﬂow detection methods like MS.
iniaturized desalting units to suppress the ions of the alkaline
obile-phase as reported by Wouters et al. [20] have the potential
o further optimize the in-line coupling with mass spectrometric
etection.
Here we report the application of 1 mm I.D. size HPAEC using
 prototype CarboPac PA200 column coupled to PAD detection
r on-line ion trap mass spectrometry for the structural assign-
ent and quantiﬁcation of N-linked oligosaccharides. To challenge
he method, heterogeneous N-glycans from various sources of
gGs were analyzed including from human plasma derived
gG, a CHO produced monoclonal antibody glyco-engineered for
on-fucosylation, a Sp2/0 mouse myeloma cell line produced
onoclonal antibody and the latter antibody additionally 2,6-
ialylated with Neu5Ac. The aim of this study was to couple
PAEC and MS  to efﬁciently characterize heterogeneous N-glycan
ixtures and to extend the range of application with respect to sen-
itivity by coupling mini-bore HPAEC with on-line MS.  Structural
ssignments based on molecular mass determination and fragment
on formations were supported by digests with exo-glycosidases
nd spiking with available N-glycans standards.
. Material and methods
.1. Reagents, standards and enzymes
Analytical reagent grade sodium acetate anhydrous (BioUltra)
nd sodium hydroxide (50%) were obtained from Sigma Aldrich
hemie (Steinheim, Germany). NaH2PO4·H20, NaCl and LiCl were
btained from Merck (Darmstadt, Germany). Acetonitrile was
urchased from J.T. Baker (Deventer, The Netherlands). All solu-
ions were prepared with water from a Milli-Q System (Millipore,
illerica, MA). Helium gas (99.999%-mol) was obtained from
inde (Munich, Germany). The N-glycan standards FA2 (Oxford
otation), A2, FA2B, and FA2G2NeuAc1 for LOD determinations
ere obtained from Prozyme (Hayward, CA). The N-glycan
tandards FA2G1NeuAc1(3) (3 denoted ˛2,3-linked Neu5Ac),
A2G2NeuAc1(3), FA2G1NeuAc1(6) (6 denoted ˛2,6-linked
eu5Ac), FA2G2NeuAc1(6), FA2G2NeuAc2(6), and FA2G2Gal1
ere obtained from TheraProteins (Barcarena, Portugal). PNGase
, CMP-Neu5Ac, the Arthrobacter ureafaciens neuraminidase
EC 3.2.1.18) releasing 2,3/6/8-linked non-reducing terminal
eu5Ac and Neu5Gc, and the recombinant human -galactoside
2,6-sialyltransferase 1 ST6Gal-I (EC 2.4.99.1) were obtained
rom Roche Diagnostics GmbH (Mannheim, Germany). The -
alactosidase from green coffee beans (EC 3.2.1.22) releasing
on-reducing terminal 1,3/4/6-linked galactose from oligosac-
harides, the Streptococcus pneumonia 1,4-galactosidase (EC
.2.1.23) hydrolyzing non-reducing terminal 1,4-galactose,
he recombinant S. pneumonia -N-acetylglucosaminidase (EC
.2.1.30) hydrolyzing 1,4-GlcNAc linked to mannose (except for
isecting GlcNAc), and the recombinant S. pneumoniae Sialidase S
EC 3.2.1.18) releasing 2,3-linked non-reducing terminal Neu5Ac
nd Neu5Gc were obtained from Prozyme (Hayward, CA).033–1034 (2016) 342–352 343
2.2. Antibodies
The monoclonal antibodies of the IgG1 type denoted mAb1,
mAb2 and mAb4 expressed in Chinese hamster ovary (CHO) cells,
the mAb3 produced in Sp2/0 mouse myeloma cells, and the puriﬁed
IgG from human plasma (h-IgG, 99%), were obtained from Roche
Diagnostics (Penzberg, Germany). All mAbs contain N-glycans only
in their Fc domains.
2.3. Preparation of N-glycans
400 g proteins was  buffer exchanged by gravity ﬂow on a
NAP-5 column (GE Healthcare, Freiburg, Germany), equilibrated
with 10 mL  and eluted with 450 L 10 mM NaH2PO4, pH 7.2.
The eluted protein was  concentrated to 50 L on a Vivaspin 500
concentrator (10 kDa cut off; Sartorius, Göttingen, Germany) by
centrifugation. The N-glycans were released by adding 2 U of
PNGase F (37 ◦C for 18 h) and isolated by passing over a Vivaspin
500 concentrator followed by washing the concentrator with
2 × 30 L water. To the total ﬂow-through and washes, water
was added to 140 L. N-glycans were digested with 20 mU neu-
raminidase, 0.5 U -galactosidase, 20 mU  1,4-galactosidase, or 6 U
-N-acetylglucosaminidase by adding the exoglycosidases to the
PNGase F digest. 2,3-linked sialic acids were removed by incu-
bating the PNGase F-released N-glycans with 120 mU  Sialidase S at
37 ◦C for 2 h.
2.4. ˛2,6-Sialylation of mAb3
The 2,6-sialylation of the Sp2/0 derived mAb3 was performed
by incubating 800 g antibody with 400 g CMP-Neu5Ac and 80 g
2,6-sialyltransferase (ST6Gal-I) in water (140 L) at 37 ◦C for 4 h.
Finally, the sialylated mAb3 was puriﬁed using a 400 L ProSep®-
vA High Capacity column (Millipore) equilibrated with ten column
volume equilibration buffer (25 mM  Tris, 25 mM NaCl, 5 mM EDTA
pH 7.1) to remove excess CMP-Neu5Ac. The column was washed
ﬁrst with four column volume equilibration buffer, then two  col-
umn volume 1 M Tris pH 7.2, and ﬁnally with four column volume
equilibration buffer. The sialylated mAb3 was eluted with two col-
umn  volume 25 mM sodium citrate pH 2.8 and the pH adjusted to
7.0 with 1 M Tris pH 9.0.
2.5. High-performance anion-exchange chromatography (HPAEC)
The N-glycan analysis was performed using a ICS2500 chro-
matography system from Thermo Fischer Scientiﬁc (Sunnyvale,
CA) controlled by the Chromeleon software (Version 6.8 SP2,
Thermo Fischer Scientiﬁc) and consisting of an AS50 autosampler
with sample cooling, a GS50 low pressure quaternary gradient
pump with an online degasser, an ED50A electrochemical detec-
tor and a ﬂow-through cell equipped with a disposable gold
electrode and a pH reference electrode. 9 L injections were per-
formed using a 10 L injection loop. The columns used included a
CarboPac PA200 (3 × 250 mm)  and a prototype mini-bore size Car-
boPac PA200 (1 × 250 mm)  obtained from Thermo Fischer Scientiﬁc
(Idstein, Germany). Both CarboPac PA200 columns are packed with
5.5 m polyethylvinylbenzene-divinylbenzene copolymer parti-
cles. These copolymer particles have at the surface electrostatically
bound microbeads of 46 nm functionalized with strong anion
exchange groups. The columns, preceded by a Borate Trap col-
umn  (4 mm × 50 mm;  Thermo Fischer Scientiﬁc, Idstein, Germany)
between the pump and the injection valve, were equilibrated with
initial conditions of the separation gradient. Using the 1 mm col-
umn, all experiments were executed at ambient temperature using
a ﬂow rate of 0.6 mL  min−1 prior to a pre-column split with a col-
umn ﬂow rate of 50 L min−1. The 3 mm column was used with
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 column ﬂow rate of 0.5 mL  min−1. Eluents were prepared by
egassing with helium and kept saturated with helium gas to
inimize adsorption of CO2. Elution was achieved with linear gra-
ients of eluent A (50 mM NaOH) and eluent B (50 mM NaOH,
00 mM NaOAc). mAb1: isocratic 0% B (0–2 min), linear acetate gra-
ients to 2% B (2–8 min), 3% B (8–15 min), 7% B (15–25 min), 50%
 (25–55 min), 100% B (55–56 min), isocratic 100% B (56–61 min),
radient to 0% B to convert the column into the hydroxide form
61–62 min), and isocratic equilibration of the column with 0%
 (62–70 min). MAb2 and h-IgG: isocratic 0% B (0–2 min), lin-
ar acetate gradients to 1% B (2–5 min), 3% B (5–25 min), 20% B
25–55 min), 50% B (55–70 min),100% B (70–70.1 min), isocratic
00% B (70.1–75 min), gradient to 0% B (75–75.1 min), and equi-
ibration with 0% B (75.1–80 min). mAb3 and mAb4: isocratic
% B (0–2 min), linear acetate gradient to 1% B (2–5 min), 3%
 (5–25 min), 20% B (25–55 min), 70% B (55–90 min), 100% B
90–90.1 min), isocratic 100% B (90.1–95 min), gradient to 0% B
95–95.1 min), and equilibration with 0% B (95.1–100 min). The
amples were injected at 0 min  and all separations were performed
t room temperature.
.6. Pre-column eluent ﬂow splitting
To obtain a ﬂow rate of 50 L min−1, a ﬂow splitter was  inserted
etween the gradient pump and the autosampler. The eluent was
plit (ratio 1:11) via a TEE (model P-727, Upchurch Scientiﬁc, Oak
arbor, WA)  connected to the analytical column and to waste.
.7. Pulsed amperometric detection
The amperometric detector was coupled to the outlet of the ana-
ytical column, and pulsed amperometric detection obtained using
he following pulse potentials and time settings: E1 = 0.1 V (td: 0.00-
.20 s, t1: 0.20-0.40 s), E2 = −2.0 V (t2: 0.41–0.42 s), E3 = 0.6 V (t3:
.43 s), E4 = −0.1 V (t4: 0.44–0.50 s). Quantitative evaluation was
erformed by integration of the PAD chromatograms using the
hromeleon software.
.8. Desalting of the HPAEC efﬂuent
The HPAEC efﬂuents contained relatively high concentrations
f non-volatile species and were made compatible with the ESI
nterface using a prototype 1 mm online carbohydrate membrane
esalter (CMD 300, Thermo Fischer Scientiﬁc, Sunnyvale, CA) [21].
or continues regeneration the desalter was connected to a AXP-
S Auxiliary Pump (Thermo Fischer Scientiﬁc) at a ﬂow rate
f 150 L min−1. Water was used as regeneration solution. The
MD  300 contains membranes functionalized with strong cation
xchange groups and exchanges sodium ions for hydronium ions.
n this set-up, hydronium ions neutralize hydroxide to water and
cetate is converted to acetic acid. Sodium ions are removed by
iffusion into the cathode compartment.
.9. Ion trap mass spectrometry
Electrospray ionization mass spectrometry (ESI–MS) and
SI–MS/MS was performed in the positive ion mode using a HCT
ltra PTM Discovery System ion trap mass spectrometer from
ruker Daltonics (Bremen, Germany). Make-up solutions were
umped into the eluent ﬂow via a TEE (model P-727, Upchurch
cientiﬁc) and a Harvard syringe pump (model PHD 2000, Harvard
pparatus, Holliston, MA)  equipped with a Hamilton 10 mL  syringe
t a ﬂow rate of 15 L min−1, and the ﬂow directed to the ESI inter-
ace of the mass spectrometer. The ESI–MS was operated using the
ollowing settings: dry gas temperature 300 ◦C, nebulizer 10 psi, dry
as 5 L min−1, capillary voltage 4 kV, target mass 800 m/z, full scan033–1034 (2016) 342–352
range 500–1500 m/z, rolling averages with ﬁve spectra. Helium
was used as collision gas. Noise reduction and spike removal was
performed using MassMap software (MassMap, Wolfratshausen,
Germany). MS/MS  was  performed in automatic mode using ramped
CID voltage (SmartFrag, 30–200% fragmentation amplitude). The
instrument was  calibrated using TuneMix (Bruker Daltonics). MS
and MS/MS  spectra were evaluated using Data Analysis software
(Bruker Daltonics). Carbohydrate structure determinations were
performed with assistance from GlycoWorkbench [22].
2.10. Quantitative single ion current evaluation
Relative quantiﬁcation of N-glycans by mass spectrometry was
performed by automatic baseline integration of speciﬁc ion current
(SIC) chromatograms on the basis of charge state 2+ and isotopes 0,1
and 2 using GRAMS AI software (Thermo Fisher Scientiﬁc, Dreieich,
Germany).
3. Results and discussion
3.1. Ionization mode and test of make-up solutions
HPAEC-MS has previously been performed with on-line addi-
tion of a make-up solution containing either LiCl or NaCl following
the on-line desalting [15,23] for improved ionization and to obtain
informative spectra including not only B- and Y-type ions but also C
and Z ions and cross-ring cleavages of the eluting oligosaccharides
(nomenclature proposed by Domon and Costello [24]). In positive
ionization mode the carbohydrates are then detected as lithiated or
sodiated adducts ([M + Li]+, [M + Na]+, [M + 2Li]2+, [M + 2Na]2+). To
test the ionization with alkali metals, we tested the inﬂuence and
the composition of make-up solutions consisting of 1 mM NaCl in
50% (v/v) acetonitrile, 1 mM LiCl in 50% (v/v) acetonitrile, and 50%
(v/v) acetonitrile. As the sodium acetate containing HPAEC eluent,
after passing the desalter converted into acetic acid, might be suf-
ﬁcient to facilitate ionization and protonated ions, we speculated
whether the make-up could possibly be omitted without further
peak dilution. Total ion current chromatograms obtained in positive
ion mode of about 300 pmol of N-glycans from mAb1, demonstrated
signal-to-noise ratios (ratio of the signal peak height to 5 times the
standard deviation of the noise) for FA2 (S/NFA2) of 17, 47 (Fig. 1A),
256, and 3049 (Fig. 1B), for the make-up solutions; 1 mM NaCl in
50% (v/v) acetonitrile, 1 mM LiCl in 50% (v/v) acetonitrile, 50% (v/v)
acetonitrile, and without the use of a make-up solution, respec-
tively, demonstrating a considerably higher sensitivity without the
use of a make-up. Without make-up solution, we  detected pro-
ton adducts and about 1% sodium adducts. The level of in-source
fragmentation (determined by comparing signal intensities of FA2
versus fragments FA1 and A2, charge states 2+) was determined to
be 15% using 1 mM  LiCl in 50% acetonitrile compared to 3% with-
out a make-up solution or 50% acetonitrile. Without make-up and
further dilution of the eluting glycan structures, the MS/MS  spectra
allowed the identiﬁcation of a total of 10 mAb1 derived N-glycans
(FA1, A1, FA1G1, FA2, M5,  A2, FA2G1, FA2G2, FA2G1, FA2G1NeuAc1,
FA2G2NeuAc1; Fig. 1C), whereas with 1 mM LiCl/50% acetonitrile,
only the most abundant N-glycans (FA2, FA2G1 and FA2G2) could
be detected. As expected we detected fucose-rearrangements [25]
only upon tandem mass spectrometry of the protonated precursor
ions.
In negative ionization mode, we  tested the following make-
up solutions in 50% methanol (v/v): 100 mM NH4OH,  100 mM
NH4OH/100 mM NH4NO3, 100 mM NH4NO3, and 200 mM NH4NO3
based on the study by Harvey [26], who  demonstrated that nitrate
adducts of the type [M + NO3]− form stable complexes with N-
glycans. With NH4OH we detected N-glycans as [M-H]− ions and
M.  Maier et al. / J. Chromatogr. B 1
Fig. 1. Total ion current chromatograms from positive ion mode HPAEC-MS of
PNGase F-released N-glycans from mAb1 with (A) a make-up solution of 1 mM LiCl
in  50% acetonitrile (v/v), and (B) without the use of a make-up solution. Signal-
to-noise ratios for FA2 (S/NFA2) are indicated. (C) Stacked extracted ion current
chromatograms obtained without make-up solution for all double-protonated N-
glycans [M + 2H]2+ detected from mAb1 (m/z values are listed). N-glycans are given
according to the Consortium for Functional Glycomics notation; the Oxford glycan
n
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The peak broadening at half height in the total ion current chro-omenclature was used for the abbreviations. Blue square (GlcNAc), red triangle
Fuc), green circle (Man), yellow circle (Gal), pink rhomb (Neu5Ac).
ith NH4OH/NH4NO3 and NH4NO3, [M + NO3]− adducted species
ere detected. Using 300 pmol of N-glycans from mAb1, the signal-
o-noise ratio for FA2 detected in negative ionization mode for the
ake-up solutions listed were determined to be between 19 and
1, demonstrating an at least 50-fold higher sensitivity in positive
onization mode without the use of a make-up solution (Fig. 1B).
nfortunately, with these make-up solutions the ESI capillary was
lugged following each run and had to be cleaned. We  speculate
hat precipitation of ammonium acetate caused this problem. As
fﬁcient ionization of the eluting N-glycans was only obtained from
rotonated precursor ions and since we did not obtain better signals033–1034 (2016) 342–352 345
with on-line addition of make-up solutions in neither positive nor
negative ion mode, we decided to directly analyze all glycan struc-
tures as protonated ions in the positive mode. With CID MS/MS of
the protonated ions, we generally observed cleavage of glycosidic
linkages only.
3.2. Evaluation of the sensitivity and the limit of detection
The maximum concentration of an analyte at the peak apex is
proportional to N½/D2, where N denotes the plate count and D the
inner diameter of the column [27]. A reduction of the inner col-
umn  diameter from 3 mm of the analytical scale mid-size CarboPac
PA200 column to 1 mm of a mini-bore version should consequently
offer a theoretical 9-fold sensitivity increase when maintaining sep-
aration performance. To evaluate the sensitivity of the PAD and
the MS  detectors, signals were evaluated by gradient elution of the
N-glycan standards FA2, A2, FA2B, FA2NeuAc1 using at least ﬁve
different levels of each oligosaccharide covering a calibration range
of 100 fmol–60 pmol. For maximum sensitivity, the PAD detector
was used with new working electrodes. The calibration curve ﬁt-
ting values and the determined limit of detection (LOD) for the
3 and 1 mm  columns are reported in Table 1. Both the PAD and
MS signals were linear over the ranges investigated with R2 coefﬁ-
cients > 0.999. The LODs were calculated based on the slope and the
standard deviation of the response estimated by ﬁve repeated injec-
tions of each analyte in the range of 400–600 fmol. Sensitivity and
determination of the LOD of the MS  was performed by integration
of extracted ion current chromatograms of the double-protonated
ions at m/z 732.32+ (FA2), m/z 659.32+ (A2), m/z  833.92+ (FA2B), and
m/z 1039.92+ (FA2G2NeuAc1).
Comparing the calibration slopes of the PAD signals obtained
with the 1 mm column with those obtained with the 3 mm column,
the mini-bore column demonstrated the expected higher sensitiv-
ity with approximately 7-, 8-, 8-, and 10-fold for FA2, A2, FA2B, and
FA2G2NeuAc1, respectively. The LODs improved approximately 2-,
6-, 8- and 5-fold for FA2, A2, FA2B, and FA2G2NeuAc1, respectively
(Table 1). The LODs in the selected ion mode for protonated adducts
of FA2, A2, FA2B, and FA2G2NeuAc1, were determined to be 47–105
fmol using the mini-bore column. The equivalent LODs obtained
with PAD were determined to be 9–59 fmol (Table 1).
3.3. Gradient optimization
The mobile phases in HPAEC have a profound inﬂuence on the
selectivity and speed of the separation with strong alkaline eluents
ensuring strong column interaction. Lowering the concentration
of NaOH from commonly used 100 mM in the eluents has been
reported to improve the resolution of neutral N-glycans analyzed
by HPAEC [28]. To ensure optimal chromatographic separation, we
tested several concentrations of NaOH between 25 and 100 mM and
for the elution of sialylated N-glycans various concentrations (up to
300 mM)  of pushing agent NaOAc. Separation e.g. between A2 and
M5 in the case of mAb1 (Fig. 1C) and reduced retention times of
sialylated N-glycans could be obtained using linear gradients with
50 mM NaOH and eluent B containing additional 200 mM NaOAc.
These eluents were therefore used throughout this study. For opti-
mal  analysis, a gradient separation was  developed for each source
of N-glycans. Extracted ion current chromatograms were used to
monitor and optimize the separation. This resulted in chromato-
graphic runs of between 70 and 100 min. (Figs. 1 C, 2, 3 and 5).matograms (without make-up solution) was  only 20% of the PAD
peak width (FA2 only) caused by the arrangement of desalter and
ESI interface of the MS.
346 M.  Maier et al. / J. Chromatogr. B 1033–1034 (2016) 342–352
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Fig. 2. HPAEC-PAD chromatograms and total ion current chromatograms from
positive-mode HPAEC-MS (intensity attenuation: 10−3 × ) of PNGase F-released N-
glycans from (A) a puriﬁed human IgG (h-IgG, 99%), and (B) an IgG1 from chinese
hamster cells, glyco-engineered for non-fucosylation (mAb2). N-glycans are given
according to the Consortium for Functional Glycomics notation. Blue square (Glc-
NAc), red triangle (Fuc), green circle (Man), yellow circle (Gal), pink rhomb (Neu5Ac).
A  spike peak is indicated by an asterisk.
3.4. Analysis of various sources of IgG Fc N-glycans
Following optimization of the chromatographic conditions, the
PNGase F-released N-glycans from human plasma (h-IgG), mAb2
and mAb3 were subjected to both HPAEC-PAD and HPAEC-MS/MS
analysis using the 1 mm CarboPac PA200 column. The peak pat-
terns obtained with HPAEC-MS were similar to those obtained
with HPAEC-PAD (Figs. 2, 3 and 5). The HPAEC-MS/MS analy-
sis of the N-glycans released from h-IgG revealed in total 15
different structures (Fig. 2A). Besides common structures like
FA2 (27 min), FA2G1 (32.5 min), FA2G2 (37 min) and monosia-
lylated structures like FA2G1NeuAc1(6) (6 denoted ˛2,6-linked
Neu5Ac) and FA2G2NeuAc1(6) (55–60 min), several bisected struc-
tures were detected like FA2 B (34.5 min), A2 B (36.0 min), FA2BG1
(37.5 min), A2BG1 (39.0 min) and FA2BG2 (40.0 min) (Fig. 2A).
Also the hybrid bisected structures; FM5A1 B (41.0 min), M5A1 B
(42.5 min), and M5A1G1 B (43.5 min) were detected (Fig. 2A). The
MS/MS  spectrum of M5A1G1 B (m/z 902.9) is shown in Fig. 6A.
The hybrid bisected structure is underpinned by the B3Y3 frag-
ment (m/z 852.3; D-ion) and B3Y3 − 221 fragment (m/z 631.0;
D-ion − 221) revealing the constitution of the 1,6-arm to be
three hexoses [29]. This is also supported by fragments Y3Y3
(m/z 790.3), B3Y3Y3 (m/z 649.0) and B3 (m/z 528.2) reveal-
M.  Maier et al. / J. Chromatogr. B 1033–1034 (2016) 342–352 347
Fig. 3. HPAEC-PAD chromatograms and total ion current chromatograms from
positive-mode HPAEC-MS (intensity attenuation: 10−3 × ) of PNGase F-released
N-glycans from mAb3 expressed in Sp2/0 mouse myeloma cells. The peaks x,
y  and z represent glycosylamines (N-glycan-1-amino-GlcNAc) of the N-glycans
FA2G1NeuGc1(6) (two peaks), FA2G2NeuGc1(6) and FA2G2NeuGc2(6), respec-
tively. N-glycans drawn based on the Consortium for Functional Glycomics notation.
Blue square (GlcNAc), red triangle (Fuc), green circle (Man), yellow circle (Gal), white
rhomb (Neu5Gc). A buffer component is indicated by an asterisk.
Fig. 4. The identity of the sialylated oligosaccharides of mAb3 eluting between 65
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Fig. 5. HPAEC-PAD chromatograms and total ion current chromatograms from
positive-mode HPAEC-MS (intensity attenuation: 10−3 × ) of PNGase F-released
N-glycans from mAb3, 2,6-sialylated with CMP-Neu5Ac. The peaks v, w, x, y
and  z contain glycosylamines of the N-glycans FA2G1NeuAc1(6), FA2G2NeuAc2(6),
FA2G1NeuGc1(6) (two peaks), FA2G2NeuGc1(6) and FA2G2NeuGc2(6), respec-
tively. N-glycans drawn based on the Consortium for Functional Glycomics notation.nd  70 min  (Fig. 3) was  conﬁrmed by HPAEC-MS and −PAD following digestions with
1,3-  and 1,4-galactosidases and -N-acetylglucosaminidase; arrows indicate the
elative inﬂuence on the level of the eluting N-glycans.
ng the constitution of the 1,3-arm to be two hexoses and one
-acetylhexosamine, see also Table S1 in Supplementary materi-
ls. Unlike other serum glycoproteins with 2,3 sialic acid residues
inked to penultimate galactose residues of N-glycans, human IgGs
ainly contain N-glycans with 2,6-linked Neu5Ac [30,31]. Conse-
uently, the Neu5Ac of the mono-sialylated FA2G1NeuAc1(6) and
A2G2NeuAc1(6) eluting between 55 and 60 min  could only be
emoved with the A. ureafaciens neuraminidase releasing 2,3/6-
inked sialic acids and not with the S. pneumoniae Sialidase S
eleasing 2,3-linked sialic acids (data not shown). Also, spik-
ng of N-glycan standards FA2G1NeuAc1(6) (6 denoted ˛2,6-linked
eu5Ac), FA2G2NeuAc1(6), FA2G1NeuAc1(3) (3 denoted ˛2,3-
inked Neu5Ac), FA2G2NeuAc1(3), conﬁrmed the 2,6-linkage of
he Neu5Ac structures of h-IgG (data not shown).Blue square (GlcNAc), red triangle (Fuc), green circle (Man), yellow circle (Gal), pink
rhomb (Neu5Ac), white rhomb (Neu5Gc). A buffer component is indicated by an
asterisk.
MAb2 expressed in CHO cells has been glyco-engineered
for non-fucosylation based on the overexpression of the 1,4-
N-acetylglucosaminyltransferase III (GnT-III) and the Golgi -
mannosidase II (ManII) for increased antibody-dependent cellular
cytotoxicity [32]. GnT-III transfers N-acetylglucosamine to the
-linked mannose in the core to generate the bisecting N-
acetylglucosamine. The presence of this residue inhibits the action
of ManII, thereby leading to an increase in especially bisected non-
fucosylated and hybrid structures. The analysis of the N-glycans
released from mAb2 revealed in total 18 different structures,
the most prominent ones being complex bisected structures A2 B
(35.5 min), FA2 B (34.0 min), and FA2BG1 (37.0 min) (Fig. 2B). As
an example, the MS/MS  spectrum of A2 B (m/z 760.9) is shown
in Fig. 6B. From the parent mass m/z 760.9 (z = 2) the compo-
sition of three hexoses and ﬁve N-acetylhexosamines is derived.
Given that the oligosaccharide is released with PNGase F a bisected
biantennary N-glycan is assumed. This is conﬁrmed with MS/MS
by the fragments with masses m/z 731.3 (B3Y3 or D ion) and
a very weak signal at m/z 510.2 (D ion − 221) [33], see Fig. 6B
and Table S2 in Supplementary materials. Compared with h-IgG,
mAb2 exhibit many of the same N-glycans (Fig. 2B), however, the
distribution is changed towards the bisected structures, and com-
plex structures like FA2 (25.0 min), FA2G1 (31.5 and 33.0 min), and
FA2G2 (36.5 min) are rather low abundant. Based on integration
of the single ion current chromatograms, the bisected structures
account for 66% of the glycan of mAb2 and for 26% h-IgG gly-
cans. The level of afucosylated structures of mAb2 and h-IgG sum
to 41% and 10%, respectively. Also hybrid bisected structures like
FM3A1 B (26.5 min), M4A1 B (30.5 min), FM5A1 B (40.0 min), and
M5A1 B (41.5 min) could be veriﬁed (Fig. 2B). As expected for ther-
apeutics expressed in CHO, the mono-sialylated FA2G1NeuAc1 and
FA2G2NeuAc1 eluting at 55.0 and 56.0 min, respectively (Fig. 2B),
contain 2,3-linked Neu5Ac as demonstrated by digestion with
Sialidase S (data not shown).Sp2/0 mouse myeloma cells generally produce mAbs with N-
glycans containing 2,6-linked Neu5Gc and small amounts of
1,3-Gal. HPAEC-MS/MS of the N-glycans released from mAb3
revealed in total 12 different structures (Fig. 3) with the most
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ntense peaks representing FA2 (22.0 min) and FA2G1 (26.5 min).
he MS/MS  spectrum of FA2G2 with one 1,3-Gal (FA2G2Gal1)
luting at 37.0 min  (Fig. 3) is shown in Fig. 6C, and further con-
rmed by spiking with a FA2G2Gal1 standard (data not shown).
rom the parent mass m/z  975.4 (z = 2) the composition of six hex-
ses, four N-acetylhexosamines and one deoxyhexose has been
erived. Given that the oligosaccharide is released with PNGase
 it represents a fucosylated biantennary N-glycan extended
ith a hexose. The glycosidic cleavage ions Y4 (m/z 1584.6)
nd Z4 (m/z 1566.5) together with the glycosidic cleavage ions
/z 708.4 and m/z 690.2 indicate that the extra hexose is sit-
ated at the non-reducing end. For more details see Fig. 6C
nd Table S3 in Supplementary materials. The Neu5Gc residues
f all sialylated N-glycans could be removed by digesting with
euraminidase but not with Sialidase S (data not shown), con-
rming the 2,6-linkage of Neu5Gc of mAb3. Interestingly, the
wo isomers of the mono-sialylated, di-galactosylated N-glycans
A2G2NeuGc1(6) (66.4 and 68.8 min) eluted prior to the corre-
ponding isomers of the mono-sialylated, mono-galactosylated
-glycans FA2G1NeuGc1(6) (66.7 and 69.1 min) (Fig. 3). This
rder of elution was further veriﬁed by HPAEC-MS and −PAD
ollowing a treatment with exo-1,4-galactosidase releasing ter-
inal galactose which almost completely turned the two  isomer
eaks of FA2G2NeuGc1(6) into two FA2G1NeuGc1(6) isomer peaks
Fig. 4). This is opposite to the order of elution of the isomers
f FA2G1NeuAc1 and FA2G2NeuAc1, where the latter elutes after
A2G1NeuAc1 no matter if Neu5Ac is in the 2,3 or 2,6 posi-
ion (Figs. 1, 2 and 3). As the separation by HPAEC is based on the
onizable hydroxyl groups of the monosaccharides, we speculate
hether the differences in elution order of FA2G2NeuGc1(6) and
A2G2NeuAc1(6) compared to their mono-galactosylated counter-
arts are due to differences in the interaction of galactose hydroxyls
ith the ionized solid phase preventing greater interaction with
he column in the case of FA2G2NeuGc1(6). As FA2G2NeuGc2(6)
luted as two peaks ( > 80 min) (Fig. 3), we speculate if the lat-
st eluting one is due to the epimerization of GlcNAc to ManNAc
34]. The two peaks eluting at 67.5 and 69.7 min  were identiﬁed
s mono-sialylated, di-galactosylated N-glycans with one 1,3-Gal
FA2G2Gal1NeuGc1(6)) by MS/MS, and the identities veriﬁed by
PAEC-MS following a digestion with 1,3-galactosidase (Fig. 4).
At 65.2 min  a structure corresponding to FA1G1NeuGc1(6)
luted among the released N-glycans of mAb3 (Fig. 3). Dur-
ng biosynthesis of N-glycans the trimming by -mannosidase
I takes place following the transfer of an N-acetylglucosamine
o C-2 of the mannose 1–3 in the core of Man5GlcNAc2
y N-acetylglucosaminyltransferase GlcNAcT-I adding an N-
cetylglucosamine residue to the 1,3 mannose in the core of
an5GlcNAc2 [35]. We  therefore assume that the peak elut-
ng at 65.2 min  corresponds to FA1G1NeuGc1(6) with Neu5Gc
n the 1,3-arm of the biantennary structure. When treating
ith -N-acetylglucosaminidase the two peaks identiﬁed as
A2G1NeuGc1(6) eluting at 66.7 and 69.1 min  were almost com-
letely absent in the PAD (Fig. 4) and TIC chromatograms (data
ot shown). As a consequence, the FA1G1NeuGc1(6) with Gal-
eu5Gc on the 1,3-arm eluting at 65.2 min  increased in intensity
s well as three other peaks containing further isobaric structures
o FA1G1NeuGc1(6) eluting at 64.5, 67.7, and 68.1 min  (Fig. 4).
y HPAEC-MS/MS, the peak at 67.7 min  proved to also include
o-eluting FA2G2Gal1NeuGc1(6) as in the untreated sample. We
peculate if the peak at 64.5 min  represents FA1G1NeuGc1(6) with
alNeu5Gc on the 1,6-arm of the biantennary structure which
s in line with the elution order of the two FA2G1 isomers. The
A1G1NeuGc1(6) eluting at 67.7, and 68.1 min  could eventually be
anNAc epimers of FA1G1NeuGc1(6) with Neu5Gc on the 1,6 and
,3 arms, respectively.033–1034 (2016) 342–352
The mAb3 peaks denoted x (two peaks eluting 45.0 and
46.0 min), y (47.1 min) and z (72 min) (Fig. 3) represented N-glycans
with masses equivalent to 1930.8 Da, 2092.8 Da, and 2400.0 Da,
respectively. The MS/MS  spectra allowed us to conclude that
all peaks contain N-glycans containing one Neu5Gc. The XICs
demonstrated that the y-peak was  no longer detectable following
digestion with exo-1,4-galactosidase, whereas both x-peaks were
unaffected (data not shown). Furthermore, all x, y, and z peaks dis-
appeared when treated with neuraminidase but not with Sialidase
S (data not shown), and the XICs of the peaks indicated that only
the intensity of the y-peak was reduced following 2,6-sialylation
with CMP-Neu5Ac (see also TIC in Fig. 5). Also the XICs conﬁrmed
that treatment with -N-acetylglucosaminidase removed the two
x-peaks. As the x-, y-, z-peaks exclusively disappeared following
incubation at 4 ◦C for 1 month or treatment with 40 mM acetic
acid at 45 ◦C for 15 min, we conclude that the peaks represent
glycosylamines of FA2G1NeuGc1(6) (two peaks), FA2G2NeuGc1(6)
and FA2G2NeuGc2(6), respectively. Glycosylamins have a mass
of −1.0 Da compared to the cyclic hemiacetal of the N-glycans.
Glycosylamines likely interact less strongly with the charged sta-
tionary phase as they possess an amino group instead of a hydroxyl
group at C-1 at the reducing end, losing the most acidic hydrox-
ylgroup [8]. Interestingly, the glycosylamines of FA2G1NeuGc1(6)
and FA2G2NeuGc1(6) elute in the expected order, but opposite to
the order of their corresponding cyclic hemiacetals eluting between
66.5–69.1 min  (Fig. 3). The two  x-peaks eluting at 45.0 and 46.0 min
are likely to be the isomeric forms with Neu5Gc on the 1,6 and
1,3 arms of the biantennary structure, respectively, separated by a
shallow gradient.
To increase the complexity of the N-glycosylation of mAb3
and to challenge the method with the separation and identiﬁca-
tion of Neu5Gc-, Neu5Ac-, and mixed Neu5Gc/Neu5Ac-containing
N-glycans, the antibody was  sialylated with Neu5Ac using
the recombinant human sialyltransferase ST6Gal-I. This trans-
ferase caps penultimate galactose with sialic acids in the
2,6 position. The reaction time was set to 4 h to minimize
intrinsic sialidase activity of the sialyltransferase. As a result
Neu5Ac- and mixed Neu5Gc/Neu5Ac-containing N-glycans like
FA1G1NeuAc1(6) (48.8 min), FA2G1NeuAc1(6) (51.5 and 54.5 min),
FA2G2NeuAc1(6) (52.5 and 55.0 min), FA2G2NeuAc2(6) (70.0 min),
and FA2G2NeuGc1NeuAc1(6) (74.5 and 77.0 min) were veriﬁed by
MS/MS  as separate peaks (Fig. 5). The MS/MS spectra recorded
in the positive ion mode of FA2G2NeuGc1NeuAc1(6) (m/z 795.9
[M + 3H]3+) eluting at 74.5 min  is shown in Fig. 6D. The B3 gly-
cosodic cleavage fragments at m/z 657.2 and m/z  673.2 show that
N-acetylneuraminic acid and N-glycolylneuraminic acid is posi-
tioned in different arms of the diantennary polysaccharide and
moreover is located at the non-reducing end. The very weak sig-
nals of fragments with m/z 981.2 (B5Y3) in combination with
m/z 891.2 (0,3A5Y3)  and in addition no signal was  observed
at m/z 997.3 are strongly indicative that Neu5Ac is at the non
reducing end of the 1,6-arm. For more details see Table S4 in
Supplementary materials. As a consequence of the sialylation
with Neu5Ac, the FA2G2 (31.5 min, Fig. 5) was completely 2,6-
sialylated and no more detectable by XIC evaluation. Also FA2G1
with galactose on the 1,3-arm eluting at 27.5 min  (Fig. 3) was
barely detectable (XIC evaluation) in the Sp2/0 material sialy-
lated with CMP-Neu5Ac. This is consistent with the observation
that the human 2,6-sialyltransferase ST6Gal-I preferentially adds
sialic acid to the 1,3-arm [36,37]. HPAEC-MS and spiking with
the N-glycan standards FA2G1NeuAc1(6), FA2G2NeuAc1(6), and
FA2G2NeuAc2(6) conﬁrmed the elution times of the Neu5Ac-
containing glycan structures. The XIC chromatogram of the peak
denoted v (m/z 958.4 (z = 2)) eluting around 23.5 min  demonstrated
two peaks representing the glycosylamines of FA2G1NeuAc1(6)
likely to be the 1,6- and 1,3-arm forms. Similarly, the w-peak con-
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Fig. 6. MS/MS  analysis of the double-protonated [M + 2H]2+ forms of (A) M5A1G1 B (m/z 902.9) of h-IgG eluting at 43.5 min (Fig. 2A), (B) A2 B (m/z 760.9) of mAb2 eluting
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ot  35.5 min  (Fig. 2B), (C) FA2G2Gal1 (m/z 975.4) of mAb3 eluting at 37.0 min (Fig.
2,6-sialylated with CMP-Neu5Ac eluting at 74.5 min  (Fig. 5). The observed ions w
GlcNAc), red triangle (Fuc), green circle (Man), yellow circle (Gal), pink rhomb (Ne
ained the glycosylamine (m/z 1185.0 (z = 2)) of FA2G2NeuAc2(6).
he XIC chromatogram of the mass equivalent to the glycosylamine
f FA2G2NeuAc1 indicated elution shortly after the two FA2G1
eaks. Somewhat surprising, we found FA1G1NeuAc1(6) to elute
t 48.8 min  (Fig. 5). We  speculate if this is caused by sialidase activ-
ty of the 2,6-sialyltransferase and/or due to contamination of
-N-acetylglucosaminidase.
.5. Relative quantiﬁcation by speciﬁc ion current
hromatograms and comparison with HPAEC-PAD and
ILIC-UPLC(2-AB)
Compared to HPAEC-PAD, HPAEC-MS has a high potential
n distinguishing and allowing optimal quantiﬁcation of co-
luting oligosaccharides. To test this and to compare the method
ith HILIC-UPLC of 2-aminobenzamide (2-AB) labelled N-glycans
mploying ﬂuorescence detection with femtomole sensitivity [38],
ur preferred in-house reference method concerning robustness,
ccuracy, and reproducibility, a relative quantiﬁcation was con-
ucted on N-glycans released from CHO produced mAb4 by speciﬁc
on current (SIC) chromatogram analysis. The SIC evaluation was
erformed involving charge state 2+ and isotopes 0, 1 and 2. N-
lycans were identiﬁed manually by searching their m/z-values
ithin the experimental mass spectrum and relative amounts were
alculated by integration of the SIC peaks. The HPAEC-MS data was
ompared to quantitative evaluations performed by HPAEC-PAD
nd HILIC-UPLC of 2-AB labelled N-glycans (Table 2). HILIC-UPLC(2-
B) was performed essentially as described by Reusch et al.
39]. Recently, we extensively characterized the N-glycosylation
f mAb4 using in total seven non-MS methods (involving CE-LIF,d (D) triple-protonated [M + 3H]3+ FA2G2NeuGc1NeuAc1(6) (m/z 795.9) of mAb3
terpreted according to the nomenclature of Domon and Costello [24]. Blue square
, white rhomb (Neu5Gc). Fucose re-localizations are indicated by asterisks.
HILIC, DSA-FACE, CCGE, and HPAEC [39]) and eleven MS based
methods (involving MALDI-TOF, QTOF, and Orbitrap [40]). From
these studies and our in-house experience we know, that the
Fc-glycosylation of mAb4 involves a total of 16 detectable N-
glycans including the two  isobaric forms of both FA2G1 and A2G1.
In our hands, both HPAEC-PAD (1 mm I.D. column), HPAEC-MS
(1 mm  I.D. column) and HILIC-UPLC(2-AB) demonstrated compa-
rable quantitative data with low standard deviations (Table 2).
With both HPAEC methods, we  demonstrate the presence of all 16
distinct N-glycans. Using HPAEC-PAD and HPAEC-MS, the mono-
galactosylated structure lacking N-acetylglucosamine (FA1G1) was
quantiﬁed to 0.4 and 0.7%, respectively. Due to co-elution with
FA2G1 with 1,4-galactose on the 1,6 arm, FA1G1 was not
detectable by HILIC-UPLC(2-AB) (Table 2, [39]). The levels of high
mannose glycan M5  was quantiﬁed to 0.7, 0.2 and 1.5% by HPAEC-
PAD, HPAEC-MS, and HILIC-UPLC(2-AB), respectively (Table 2).
Column charge dependent, M5 did not elute completely base-lined
separated from FA2 by HPAEC and might therefore be slightly
underestimated by HPAEC-PAD. The underestimation by HPAEC-
MS is likely due to ion suppression from intensive FA2 signals.
Quantiﬁcation by the seven different non-MS methods and the
eleven MS  based methods resulting in average 1.8% [39] and 1.6%
M5  [40], respectively, further support the slight underestimations
by both HPAEC methods. We  believe further chromatographic
optimization ensuring optimal separation of M5 and FA2 could
eliminate this problem. Sialic acid-containing N-glycans are prone
to fragmentation compared to neutral ones, which result in-source
or metastable decay [41]. This is likely the explanation of the
slightly lower levels of some of the sialylated structures of mAb4
by positive mode HPAEC-MS (Table 2).
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Table 2
Quantiﬁcation by integration of the HPAEC-PAD and HPAEC-MS speciﬁc ion current (SIC) chromatograms of PNGase F-released N-glycans from mAb4 and comparison with
quantitative data from HILIC-UPLC of 2-AB labelled N-glycans. Relative abundances are given (bold), followed by standard deviations.
an = 6.
bSIC evaluation involving charge state 2+ and isotopes 0,1 and 2.
cData from Reusch et al. [39], n.d.; not detected. The N-glycan structures are based on the Consortium for Functional Glycomics notation.
dThe Oxford glycan nomenclature (bold) was used for the abbreviations (alternative naming in parentheses). Blue square (GlcNAc), red triangle (Fuc), green circle (Man),
yellow  circle (Gal), pink rhomb (Neu5Ac).
Table 3
Quantiﬁcation by integration of HPAEC-MS speciﬁc ion current (SIC) chromatograms of PNGase F-released N-glycans from mAb2 and comparison with quantitative data from
HILIC-UPLC of 2-AB labelled N-glycans.
an = 1.
bSIC evaluation involving charge state 2+ and isotopes 0,1 and 2, n.q.; not quantiﬁable. The N-glycan structures are based on the Consortium for Functional Glycomics notation.
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ellow  circle (Gal), pink rhomb (Neu5Ac).
As relative quantiﬁcation by HPAEC-MS might be even more
eneﬁcial for more heterogeneous samples of N-glycans, we fur-
her analyzed and quantiﬁed the N-glycans of mAb2 by HPAEC-MS
nd HILIC-UPLC(2-AB). The identiﬁcation of the HILIC-UPLC(2-AB)
eaks was supported by coupling with MS.  By HILIC-UPLC(2-AB),
2 B and FA2 were found to co-elute, as well as FA2 B and FM3A1B,
nd A2G1 and M4A1B, respectively (Table 3). Furthermore, M5
luted as a shoulder of the co-eluting FA2 B and FM3A1 B and was
ot quantiﬁable by HILIC UPLC(2-AB) (Table 3). In comparison, all
Ab2 N-glycans could be quantiﬁed by SIC evaluation (Table 3).ing in parentheses). Blue square (GlcNAc), red triangle (Fuc), green circle (Man),
4. Conclusion
Long has HPAEC been an efﬁcient separation tool for carbohy-
drates and a very sensitive method in the combination with pulsed
amperometric detection. Although new mass spectrometry based
and high-resolving separation based methods like porous graphi-
tized carbon, reverse phase and hydrophilic interaction liquid
chromatography of unlabeled or labelled N-glycans have evolved,
HPAEC coupled with MS  with its selectivity towards carbohydrate
charge, composition, size and linkage positions of oligosaccharides
is a competitive technique in the characterization of complex sam-
ples. A major beneﬁt of HPAEC is still that it does not require
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erivatization or any clean-up procedures of the released N-glycans
o quantitate and characterize even low abundant glycan species.
he biggest challenge in coupling HPAEC with MS is, however, to
emove the high concentrations of salts from the mobile phases
rior to detection by MS,  which is done by using a suppressor that
xchanges Na+ ions with H+ ions.
Here we tested the coupling of mini-bore HPAEC with MS  for
he structural assignment and quantiﬁcation of heterogeneous
ources of IgG derived N-glycans. With the mini-bore column we
btained a signiﬁcant limit of detection improvement of 2–8 folds
or N-glycan standards compared with an analytical scale 3 mm
olumn. We  could demonstrate femtomole sensitivities for both
AD and MS  detection using the 1 mm column. HPAEC-MS/MS
llowed the assignment of a signiﬁcant number of major and minor
eaks to N-glycan structures including complex-type, high man-
ose, hybrid and hybrid bisected structures. We  conclude that the
oupling of mini-bore HPAEC to MS  demonstrated a superior per-
ormance with respect to selectivity in the relative quantiﬁcation
f complex mixtures of N-glycans. With the gain in sensitivity com-
ared to analytical scale mid-size (3 mm I.D.) HPAEC, the mini-bore
PAEC-MS/MS method is an attractive and stable method in the
iomedical research and for the characterization of e.g. IgG bio-
harmaceuticals, especially when the glycosylation pattern is more
eterogeneous like in the case of glyco-engineered mAbs.
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